Cancer Research Cancer Health Disparities Conference 2009  Cancer Genome no Abstract
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kettunen, H. L.
Right arrow Articles by Rautonen, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kettunen, H. L.
Right arrow Articles by Rautonen, N. E.
[Cancer Research 63, 5136-5142, August 15, 2003]
© 2003 American Association for Cancer Research


Immunology

Intestinal Immune Responses in Wild-Type and ApcMin/+ Mouse, a Model for Colon Cancer1

Hannele L. Kettunen2, Anu S. L. Kettunen and Nina E. Rautonen

Danisco Innovation, FIN-02460 Kantvik, Finland

C57BL/6J ApcMin/+ (ApcMin/+) mice spontaneously develop pretumoric adenomas into the intestinal mucosa. We studied the relationship between the intestinal immune responses and adenoma formation in ApcMin/+ mice and compared ApcMin/+ mice with their wild-type siblings. Three time points (5, 8, and 15 weeks of age) and three high-fat dietary treatments (a non-fiber control with beef or inulin amendment) were included. The numbers of CD8+ T lymphocytes and tissue macrophages (Mac-1+ cells) per villus in ileal mucosa were determined by immunohistology, and the concentrations of secretory IgA, residual prostaglandin E2 (PGE2), tumor necrosis factor {alpha}, and interleukin (IL)-12 in ileal contents were analyzed by ELISA. The crypt-villus ratio of the ileal mucosa was determined histologically. An immunostimulation, characterized by an increase in several parameters (PGE2, IgA, Mac-1, and CD8), was observed in both genotypes between weeks 5 and 8. Most of the adenomas in ApcMin/+ mice also appeared during the same period of sexual maturation. Females had smaller adenomas than males, and the beef group had fewer and smaller adenomas than the control group at 15 weeks. Females had less IgA and fewer Mac-1+ and CD8+ cells in ileal tissue than males at 15 weeks and more luminal IL-12 than males at 8 weeks. Puberty may have affected both tumorigenesis and intestinal immune responses in the ApcMin/+ mouse. The beef group showed less luminal IgA and tumor necrosis factor {alpha} but more IL-12 than the control group. The concentration of PGE2 correlated positively with the number and size of adenomas and was higher in the ApcMin/+ mice than in wild-type mice at 15 weeks. IgA and Mac-1 were positively correlated with the size of adenomas at 15 weeks. The positive correlations between tumor size and IgA and between tumor number and size and PGE2 suggest that a balance toward the Th2 type immune response may affect the pace of tumorigenesis in this model. The general similarity of the intestinal immune responses in both genotypes and the lack of intestinal inflammation in the ApcMin/+ mice suggest that the mutation in the adenomatous polyposis coli gene does not lead to major alterations in intestinal immune function and that the intestinal immunology does not explain tumorigenesis in the ApcMin/+ mouse model.




This article has been cited by other articles:


Home page
ScienceHome page
S. Rakoff-Nahoum and R. Medzhitov
Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88
Science, July 6, 2007; 317(5834): 124 - 127.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
J. Parker, E. O. Oviedo-Rondon, B. A. Clack, S. Clemente-Hernandez, J. Osborne, J. C. Remus, H. Kettunen, H. Makivuokko, and E. M. Pierson
Enzymes as Feed Additive to Aid in Responses Against Eimeria Species in Coccidia-Vaccinated Broilers Fed Corn-Soybean Meal Diets with Different Protein Levels
Poult. Sci., April 1, 2007; 86(4): 643 - 653.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. Wang, H. Wang, J. Brown, T. Daikoku, W. Ning, Q. Shi, A. Richmond, R. Strieter, S. K. Dey, and R. N. DuBois
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
J. Exp. Med., April 17, 2006; 203(4): 941 - 951.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. D. Chell, I. R. Witherden, R. R. Dobson, M. Moorghen, A. A. Herman, D. Qualtrough, A. C. Williams, and C. Paraskeva
Increased EP4 Receptor Expression in Colorectal Cancer Progression Promotes Cell Growth and Anchorage Independence.
Cancer Res., March 15, 2006; 66(6): 3106 - 3113.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.A. Hull, O.O. Faluyi, C.W.S. Ko, S. Holwell, D.J. Scott, R.J. Cuthbert, R. Poulsom, R. Goodlad, C. Bonifer, A.F. Markham, et al.
Regulation of stromal cell cyclooxygenase-2 in the ApcMin/+ mouse model of intestinal tumorigenesis
Carcinogenesis, March 1, 2006; 27(3): 382 - 391.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. P. Rao, T. Poutahidis, Z. Ge, P. R. Nambiar, B. H. Horwitz, J. G. Fox, and S. E. Erdman
Proinflammatory CD4+CD45RBhi Lymphocytes Promote Mammary and Intestinal Carcinogenesis in ApcMin/+ Mice
Cancer Res., January 1, 2006; 66(1): 57 - 61.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. K. Roy, Y. L. Kim, R. K. Wali, Y. Liu, J. Koetsier, D. P. Kunte, M. J. Goldberg, and V. Backman
Spectral Markers in Preneoplastic Intestinal Mucosa: An Accurate Predictor of Tumor Risk in the MIN Mouse
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1639 - 1645.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. A. Mehl, J. M. Davis, J. M. Clements, F. G. Berger, M. M. Pena, and J. A. Carson
Decreased intestinal polyp multiplicity is related to exercise mode and gender in ApcMin/+ mice
J Appl Physiol, June 1, 2005; 98(6): 2219 - 2225.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. G. Backlund, J. R. Mann, V. R. Holla, F. G. Buchanan, H.-H. Tai, E. S. Musiek, G. L. Milne, S. Katkuri, and R. N. DuBois
15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer
J. Biol. Chem., February 4, 2005; 280(5): 3217 - 3223.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. R. Holla, D. Wang, J. R. Brown, J. R. Mann, S. Katkuri, and R. N. DuBois
Prostaglandin E2 Regulates the Complement Inhibitor CD55/Decay-accelerating Factor in Colorectal Cancer
J. Biol. Chem., January 7, 2005; 280(1): 476 - 483.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. Pierre, A. Freeman, S. Tache, R. Van der Meer, and D. E. Corpet
Beef Meat and Blood Sausage Promote the Formation of Azoxymethane-Induced Mucin-Depleted Foci and Aberrant Crypt Foci in Rat Colons
J. Nutr., October 1, 2004; 134(10): 2711 - 2716.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. A. Hull, S. C.W. Ko, and G. Hawcroft
Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer?
Mol. Cancer Ther., August 1, 2004; 3(8): 1031 - 1039.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.